Edesa Biotech ROIC
Mi az Edesa Biotech ROIC?
A ROIC az Edesa Biotech, Inc. - -81.83%
Mi a ROIC meghatározása?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC a Health Care szektor a NASDAQ-on cégekben a Edesa Biotech -hoz képest
Mit csinál Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
roic -hoz hasonló cégek Edesa Biotech
- Softlab9 Software Solutions nak ROIC -82.72% van
- Xref nak ROIC -82.46% van
- Enochian Biosciences Inc nak ROIC -82.45% van
- Good2 Go4 Corp nak ROIC -82.39% van
- Li3 Lithium Corp nak ROIC -82.37% van
- YayYo nak ROIC -81.91% van
- Edesa Biotech nak ROIC -81.83% van
- Indus nak ROIC -81.80% van
- Experion nak ROIC -81.70% van
- Monopar Therapeutics Inc nak ROIC -81.69% van
- F45 Training nak ROIC -81.63% van
- Willow Biosciences nak ROIC -81.56% van
- Althea nak ROIC -81.52% van